NSC |
Compound |
Enrichment |
Correlation |
NSC 695788 |
N(sup .alpha.)-[4-[(2,4-Diamino-5-methylpyrido[2,3-d] pyrimidin-6-yl)methyl]amino]benzoyl-n(sup .delta.)-hemiphthaloyl-L-ornithine |
4.24778409539024e-005 |
0.58812343 |
NSC 755267 |
Null |
4.24778409539024e-005 |
0.43559495 |
NSC 225112 |
2,4,6-Quinazolinetriamine, N(6)-[(3,4-dichlorophenyl)methyl]-N(6)-ethyl-5-methyl- |
4.46503794379037e-006 |
0.77004647 |
NSC 697194 |
Decanediamide, N,N'-bis[2-(2-hydroxy-1-naphthalenyl)- 5-(3,4-dimethoxyphenyl)methylene]-4-oxo- 3-thiazolidinyl]- |
5.09419714526523e-005 |
0.24528565 |
NSC 734307 |
3,4-Dihydroxy-N(3-O-methyl-estra-1,3,5(10)-trien-ol-17b-yl)c innamide |
5.09419714526523e-005 |
0.42198184 |
NSC 752464 |
methyl 2-((S,3Z)-6-((E)-1-hydroxy-3-phenylallylidene)-5-oxocyclohex-3-enyl)acetate |
5.09419714526523e-005 |
0.32816439 |
NSC 757113 |
METHOTREXATE(+/-) |
5.09419714526523e-005 |
0.67695647 |
NSC 112846 |
N-[p-[[(2,4-Diamino-6-quinazolinyl)methyl]amino]benzoyl]-L-aspartic acid |
5.09419714526527e-005 |
0.69419448 |
NSC 675988 |
11H-[1]Benzothiopyrano[2,3-e]imidazo[1,2-a]pyridine- 2-carboxamide, N-[3-(dimethylamino)propyl]-11-oxo- |
5.26048017395702e-005 |
0.31550205 |
NSC 351521 |
Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) |
5.82211804338771e-005 |
0.66741126 |